First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma.

NCT01964287 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Pancreatic Adenocarcinoma

Interventions

DRUG: GEMBRAX
DRUG: FOLFIRINOX

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle